Abstract -Eleutherococcus senticosus Maxim. has been successfully used as an oriental medicine for various diseases including allergic disorders. Histamine is a major factor on various allergic responses and it is reported that histamine was released from mast cells by sensitization of allergens. In this study, ethanol extracts from E. senticosus Maxim. were prepared and the composition was analyzed by high performance liquid chromatography. The eleutheroside B as a primary effective component of E. senticosus was contained approximately 225 mg/kg in root bark extracts. The extracts were found to significantly inhibit compound 48/80-induced histamine release form mast cells in dose dependent manner. However the extracts had low cytotoxicity on the mast cells with MTT assay. These results showed that E. senticosus Maxim. extracts may be the effective materials on inflammatory disorders.
Introduction
Eleutherococcus senticosus Maxim. (Araliaceae; also called Siberian Ginseng) has been used as a rough drug to treatment of various physiological disorders (Nishibe et al., 1990; Fujikawa et al., 2005) . The leaves or stems of E. senticosus have also been used clinically for treatment of various allergic diseases in Asia. But, it is still unclear the action mechanism, and a few studies documented the anti-inflammatory effects of E. senticosus extract using in vitro (Jung et al., 2003; Tokiwa et al., 2006) . On the other hand, the eleutherosides were well identified as a primary contents of E. senticosus Maxim, and these have been shown to be responsible for the adaptogenic properties of this plant (Hikino et al., 1986) .
Syringin and its alycone (eleutherosides B) are widely regarded as two important substances of the eleutheroside group (Niu et al., 2008) .
Atopic dermatitis (AD) is a chronic inflammatory skin disease with a wide range of severity, and is usually the first phenomenons of atopic disease. Expression of AD results from a complex interaction of environmental factors, defects of skin barrier, and immune disorders (Dubrac et al., 2010) . It is one of the most common skin disorders in developed countries, affecting approximately 20% of children and 1-3% of adults (Simpson, 2010) . AD is generally reported to be a model of typical type 2 helper T cell (Th2)-mediated disorders and has been consistently shown that skin-infiltrating Th2 chemokines producing cells (Nakazato et al., 2008) .
Mast cells have been reported major role in the development of many physiologic changes during allergic responses including of atopic dermatitis (Kim and Lee, 1999) . Mast cells activations were induces degranulation and the external release of granuleassociated stored mediators such as histamine, neutral proteases, reagent to study the mechanism of mast cell activation-mediated allergic disorder like anaphylaxis (Kim et al., 1998a) . In the present study, we examined the effects of the extracts of E. senticosus Maxim. on mast cell activation-mediated histamine releases. 
Materials and Methods

Reagents
Extraction of plant materials
Dried powders of root barks, stem barks and leaves (10 g) were extracted with 70% ethanol (500 mL) in 80℃, refluxed for 1 h, twice, and filtered through filter paper (Advantec, Toyo, Japan). The ethyl alcohol extracts were evaporated to dryness and dissolved in 50 ml of HPLC grade water.
The water fraction was washed two times with the same volume of ether. The water fraction was evaporated to dryness and dissolved in 5 ml of 70% ethanol and filtered through 0.45 µm PTEF filter (Gelman, USA).
Animals
Male Sprague-Dawley 6-week-old rats were purchased from Orient Bio (Sungnam, Korea), were acclimated to the facility for 5 d and fed and ad libitum with regular chow Animals were maintained in an environmentally controlled rearing system and used for experiments.
Isolation of peritoneal mast cells
Rat peritoneal mast cells were isolated from adult female Sprague-Dawley rats, 170-200 g, by the modified method of Kim et al. (1998b) . Briefly, after intraperitoneal injection of 10 ml of cold DMEM with 5 unit/ml of heparin, the abdomen was gently massaged for 2 min. Mast cell suspension was carefully aspirated and centrifuged at 400 ×g for 10 min. Mast cells were purified by Percoll density gradient according to the method of Hachisuka et al. (1988) . Purified mast cells were washed twice with HBSS containing 1 mg/ml bovine serum albumin.
Measurement of Cytotoxicity
Cytotoxicity was assayed by MTT assay (Mosmann, 1983) .
Mast cells (100 μl as 2 × 10 4 cells/ml) were incubated in 96 well plate (SPL Laboratory Co, Pocheon, Korea) for 1 h and treated extracts with various doses for 1 h in CO2 incubator.
After the cells were incubated in PBS containing 0.5 mg/ml
MTT for 3 h at 37℃, they were centrifuged at 1,500 × g for 10 min to recover of cells. Cells were dissolved with dimethylsulfoxide (DMSO) for 20 min and the absorbances were read at 570 nm with multiwell plated reader (Molecular devices, USA).
Histamine release by compound 48/80 and histamine assay
The mast cell suspension was divided into three parts, 
HPLC Analysis
The eleutherosides fraction was analyzed by using HPLC After the cells were incubated in PBS containing 0.5 mg/ml MTT for 3 h at 37℃, they were centrifuged at 1,500 × g for 10 min to recover of cells. Cells were dissolved with DMSO for 20 min and the absorbances were read at 570 nm with multiwell plated reader. Data are expressed as a mean ± S.E.M from three independet experiments. *p<0.05 and *p<0.01 versus non-treated group.
Statistical Analysis
Data are expressed as mean S.E.M. Statistical comparisons were performed using oneway ANOVA. Significant differences between groups were determined using the unpaired Student's t test. Statistical significance was set at p<0.05.
Results and Discussion
Analysis of active substance from Eleutherococcus senticosus extracts
Analysis of active substance from E. senticosus extracts was carried out by HPLC. Table 1 shows the contents of eleutheroside B and E, primary effective substances of E.
senticosus in extracts from various plant parts (root bark, stem bark, and leaf). The amounts of eleutheroside B in extracts of root bark, stem bark, and leaf were 225 ± 12.4, 85.8 ± 8.2, and 45.6 ± 5.6 mg/kg raw materials, respectively. The amounts of eleutheroside E, the other effective substance of E.
senticosus, were 378 ± 28.6, 388 ± 35.3, and 406 ± 38.6 mg/kg raw materials from root bark, stem bark, and leaf, respectively (Table 1) . Especially, extracts from root bark of E. senticosus contained significantly high amount of eleutheroside B, compared to stem bark, and leaf extracts. However, no differences in eleutheroside E contents between extracts of both compartments was observed. Therefore, we chose root bark extracts and used them for further experiments.
Cytotoxicity of E. senticosus extracts on mast cells
The cytotoxicity of E. senticosus extracts on rat peritoneal mast cells was evaluated by MTT assay (Fig. 1) . When cells were treated with 0.06 to 2 mg/ml of extracts which is relatively high concentration, 1 mg/ml of extract was induced decrease of viability to 79.2 ± 2.9%. Indeed, when treated with 2 mg/ml of extract, the viability was decreased to 61.5 ± 1.3%. However, no significant difference in their cytotoxicity was observed when cells were treated with 0.5 mg/ml extract and lower concentration. Therefore we decided safe dosage to 0.125 mg/ml of extract, which is maintained >90% viability, for further experiments.
Inhibition of compound 48/80-induced histamine release
Eleutherococcus senticosus extracts
We next evaluated the effect of E. senticosus extracts on histamine release from mast cells (Fig. 2) . Mast cells were pretreated with extracts (0.125 mg/ml) or HBSS for 15 min and stimulated with compound 48/80 (final concentration:
6 μg/ml). When mast cells were stimulated with compound 48/80, histamine releases were increased 27.4 ± 1.5% then negative control group. However pretreatment of E. senticosus extracts to mast cell completely reduced compound 48/80-induced histamine release from mast cells. Indeed, E. senticosus Fig. 2 . E. senticosus extracts were reduced compound 48/ 80-induced histamine release from mast cells. The mast cell suspension was divided (100 μl as 2 × 10 4 cells/ml) and incubated for 1 h, After treatment with presence or absence of extracts (0.125 mg/ml) for 15 min in CO 2 incubator, 0.1 ml of compound 48/80 (12 μg/ml) was added to all the samples except negative control and the suspensions were further incubated for 15 min at 37℃. After centrifugation at 15,000 × g for 10 min, the supernatants were collected and cold-dried. Re-suspended samples were measured histamine contents. Data are expressed as a mean ± S.E.M from three independet experiments. *p<0.05 and *p<0.01 versus non-treated group.
extracts did not induce histamine releases (data not shown).
These results suggest that E. senticosus extracts have a preventive effects of mast cells activation.
Discussion
E. senticosus is known to contain several substances such as acanthosides, eleutherosides, chiisanoside, senticoside, triterpenic saponin, syringin, flavone, vitamins and minerals, and they are responsible for many biological activities (Davydov and Krikorian, 2000) . Indeed, some researchers examined ameliorative effects of whole extracts from root, stem, and leaf of E. senticosus (Yi et al., 2001 (Yi et al., , 2002 or cultured plants (Jeong et al., 2001) against allergic responses or allergic diseases, but did not observe protective effect against histamine release from mast cells.
Cytotoxicity tests with in vitro condition are important for the evaluation of biosafety of biometerials or medicines (Mosmann, 1983) . In this study, we pre-treated the extracts with 0.125 mg/ml to mast cells because it maintained higher cell viability (Fig. 1) , and these results were similar to other reports with various models (Jang et al., 2003; Lin et al., 2007 Lin et al., , 2008 .
Eleutheroside B and E as primary substances of E. senticosus
were analyzed in present study. The contents of these biological substances in extracts were dependent on species of eleutherococcus, part of plants, and extraction methods (Kim et al., 1996; 
